Log In
Or create an account ->
Imperial Library
Home
About
News
Upload
Forum
Help
Login/SignUp
Index
Contents
Contributors
Section I The basis for and regulation of drug use in sport
Chapter 1 An introduction to drugs and their use in sport
1.1 Definition of a drug
1.2 Classification and description of drug names
1.3 Development of new drugs
1.4 Dosage forms for drug delivery to the body
1.5 The absorption, distribution, metabolism and elimination of drugs
Absorption
Distribution
Metabolism
Elimination
1.6 Effect of exercise on pharmacokinetics
1.7 Drugs and their targets
1.8 Agonists and antagonists
1.9 Side effects of drugs
1.10 Complex drug reactions
1.11 Drugs and the law
The definition of a medicinal product
Classes of medicinal products
1.12 Why drugs are used in sport
Legitimate therapeutic use of drugs
Performance continuation
Recreational/social use
Amphetamines
Cocaine
Caffeine
Narcotics
Alcohol
Cannabinoids
Performance enhancement
1.13 References
Chapter 2 A historical perspective of doping and anti-doping in sport
2.1 Introduction
2.2 The ancient Olympic and Roman games
2.3 Nineteenth century
2.4 Early twentieth century
2.5 Nineteen forties and nineteen fifties
2.6 Nineteen sixties
2.7 Nineteen seventies
2.8 Nineteen eighties
2.9 Nineteen nineties
2.10 Two thousand and beyond
2.11 The race between doping and anti-doping
2.12 References
Chapter 3 Medicines for Olympic and Commonwealth Games
3.1 Introduction
3.2 The Games polyclinic
3.3 Medical services at sporting venues
3.4 The Games formulary
Drugs for the Winter Games versus Summer Games
Drugs for dental use
Drugs for disasters
Tropical and international medicine
Traditional medicines
Quality testing of drugs
3.5 Patterns of drug use
3.6 Prescribing procedures
Prescribing by team doctors
Importation of drugs for team use
3.7 Drug information services
3.8 Summary
3.9 References
Section 2 Substances and methods prohibited in sport
Chapter 4 Anabolic agents
4.1 Introduction
4.2 The testosterone family
Biosynthesis
The biochemistry and physiology of testosterone
Mode of action of testosterone
Metabolism
The physiological role of testosterone
Androgenic effects
Anabolic effects
4.3 Structural analogues of testosterone: the anabolic steroids
Clinical uses of androgens/anabolic steroids
Replacement therapy in men
Replacement therapy in women
Gynaecological disorders
Protein anabolism
Anaemia
Osteoporosis
Growth stimulation
Side effects of androgens
In females
In children
In males
General side effects
4.4 Anabolic steroids and sport
Sources, supply and control
Patterns of administration and use
Cycling
Pyramiding
Stacking
The prevalence of anabolic steroid abuse
Efficacy of anabolic steroids
Effects on muscle
Effects on behaviour
Effects on muscle repair
4.5 Precursors, nandrolone and steroid metabolites
5-α-dihydrotestosterone (DHT)
Nandrolone
4.6 Anabolic steroid side effects with particular reference to athletes
Cardiovascular
Blood volume
Salt and water retention
Hypertension
Ventricular function
Effects on blood lipids and lipoproteins
Blood-clotting
Carcinomas
Sex-related side effects
Fertility
Effects on libido
Gynaecomastia
Specific actions in female athletes
Tendon damage
Glucose regulation
Behavioural effects and addiction
Long-term risks of anabolic steroid abuse
Indirect consequences of anabolic steroid abuse
4.7 Detection of testosterone and anabolic steroids
Tests for anabolic steroids
Detection of testosterone misuse
Steroid profiling
Cooperation with law enforcement agencies
4.8 Other anabolic agents
Clenbuterol and other Beta-2 agonists (β2-agonists)
Selective androgen receptor modulators (SARMs)
Tibolone
4.9 References
Chapter 5 Peptide hormones and related substances
5.1 Introduction
5.2 Erythropoiesis-stimulating agents
5.3 Human growth hormone (hGH)
Introduction
Release of human growth hormone
Human growth hormone action
Effects on muscle
Effects on bone
Effects on metabolism
Effects on adipose tissue
Effects of exercise on hGH
Administration and supply of hGH
Growth hormone disorders
5.4 The abuse of hGH in sport
Side effects associated with hGH abuse in sport
Who abuses growth hormone and why?
Detection of hGH abuse
The indirect “markers” approach to hGH doping detection
The direct “isoform” approach to hGH doping detection
5.5 Human chorionic gonadotropin (hCG)
Therapeutic use
hCG abuse in sport
Side effects of hCG in sport
Prevalence of hCG abuse
5.6 Luteinizing hormone (LH) and its use in sport
5.7 Insulin and its use in sport
5.8 Corticotropins
Administration of ACTH
Abuse of ACTH
Detection of ACTH
5.9 References
Chapter 6 Beta-2 agonists
6.1 Introduction
6.2 Asthma and its treatment
Definition
Epidemiology
Pathophysiology
Trigger factors
6.3 Exercise and asthma
Prevalence of asthma in athletes
Pathogenesis of exercise-induced asthma (EIA)
6.4 Management of asthma
Stepping down
6.5 Management of exercise-induced asthma (EIA)
Non-drug treatment
Drug treatment with β2-agonists
6.6 Pharmacology of b2-agonists
Bronchodilation
Anabolic effects of β2-agonists
6.7 β2-agonists and the WADA prohibited list
Therapeutic Use Exemption regulations with respect to β2-agonists
6.8 The use of β2-agonists in sport
Prevalence of β2-agonists in sport
Cases involving β2-agonists
Barcelona Olympics, 1992
The “Festina Affair”, 1998
Jessica Hardy, 2008
Do β2-agonists enhance performance?
6.9 References
Chapter 7 Hormone antagonists and modulators
7.1 Introduction
7.2 Hormone antagonists and modulators and the WADA prohibited list
7.3 Clinical use of hormone antagonists and modulators
Aromatase inhibitors
Selective oestrogen receptor modulators (SERMs)
Other anti-oestrogenic substances
Agents modifying myostatin function(s)
7.4 The use of hormone antagonists and modulators in sport
7.5 References
Chapter 8 Diuretics and other masking agents
8.1 History of diuretics and other masking agents in sport
Case studies involving masking agents
Pedro Delgardo, 1988
8th Swimming World Championships, Australia, 1998
World Nordic Skiing Championships, Finland, 2001
Zach Lund, 2006
8.2 Action and use of diuretics in sport
Clinical uses of diuretics
Diuretics as masking agents
Diuretics in sports requiring weight limitation or categorisation
Diuretic use with other prohibited substances
Other uses of diuretics associated with sport
8.3 Action and uses of other masking agents in sport
Probenecid
Plasma expanders
Epitestosterone
Alpha reductase inhibitors
8.4 Current WADA classification of diuretics and masking agents
8.5 References
Chapter 9 Enhanced oxygen transfer
9.1 Introduction
9.2 Physiology
Erythropoiesis
Oxygen transport
Regulation of erythropoiesis
Erythropoietin in health
9.3 Erythropoietin
Mode of action of erythropoietin
Recombinant erythropoietin
Detection of EPO
Abuse of EPO
9.4 Blood doping
Blood transfusion
Methods of blood doping
Testing for blood doping
Abuse
9.5 Blood substitutes
Haemoglobin-based oxygen carriers (HBOCs)
Perfluorocarbons (PFCs)
9.6 Haemoglobin modifiers
Plasma volume expanders
9.7 Actovegin
9.8 Biological passports
9.9 Conclusion
9.10 References
Chapter 10 Prohibited methods
10.1 Current (2010) WADA regulations with respect to chemical and physical manipulation
10.2 Prevalence of chemical and physical manipulation in sport
WADA statistics relating to chemical and physical manipulation
Case studies of attempted chemical and physical manipulation
Katrina Krabbe, 1992
Michelle de Bruin (née Smith), 1998
Galabin Boevski, 2003
Rebeca Gusmão, 2007
Olga Yegorova, 2008
10.3 Techniques for identifying chemical and physical manipulation
10.4 References
Chapter 11 Gene doping
11.1 Introduction
11.2 Methods of genetic modification
11.3 Genes that might enhance athletic performance
11.4 Methods of detection
11.5 The practicalities and risks of gene doping
11.6 Summary
11.7 Acknowledgements
11.8 References
Chapter 12 Stimulants
12.1 History of stimulant use in sport
Case studies related to stimulants
Tommy Simpson
Kelli White
Andreea Raducan
Alain Baxter
Martina Hingis
Richard Gasquet
12.2 Types of stimulants and their modes of action
Ephedrine, methylephedrine and cathine
Amphetamines
The mode of action of amphetamine
Pharmocokinetics
The effect of amphetamines on human mood and performance
Adverse effects of amphetamines
Cocaine
Pharmacology
Pharmacokinetics
Adverse effects
12.3 Stimulants and sport
Ephedrine and other sympathomimetics in sport
Adverse effects of sympathomimetics in athletes
Amphetamines in sport
Adverse side effects of amphetamines in athletes
Effects of cocaine in athletes and on exercise
Adverse effects of cocaine in athletes
12.4 Stimulants and the WADA prohibited list
12.5 References
Chapter 13 Narcotic analgesic drugs
13.1 Introduction
13.2 Pain and nociception
13.3 Mechanism of action of narcotic analgesics
13.4 Side effects of narcotic analgesics
13.5 The use of narcotic analgesics in sport
Indirect enhancement of performance
Cycling
Long-distance running
Runner’s high
Equestrian sport
World Anti-Doping Agency statistics
Therapeutic Use Exemption
13.6 References
Chapter 14 Cannabinoids
14.1 What are cannabinoids?
The source of cannabinoids
Mode of action of cannabinoids
Effects and side effects of cannabinoids
Cannabis use in society
14.2 History of cannabis in sport
Addition to the prohibited list
Case studies relating to cannabinoids
Ross Ribagliati, 1998
Tomas Enge, 2002
Michael Phelps
14.3 Cannabinoids in sport
The use of cannabinoids within sport
Are cannabinoids performance enhancing?
Adverse effects of cannabinoids in sport
The consequences of cannabinoid use for other competitors
14.4 Cannabinoids and the WADA prohibited list
WADA regulations with respect to cannabinoids
Prevalence of adverse findings for cannabinoids
Passive ingestion of cannabinoids
Should cannabinoids be on the WADA prohibited list?
14.5 References
Chapter 15 Glucocorticosteroids
15.1 Introduction
15.2 The functions and side effects of glucocorticosteroids
Mechanisms of action of glucocorticoids
15.3 Local steroid injections
15.4 Other uses of glucocorticoids
15.5 WADA regulations for the use of glucocorticosteroids
15.6 References
Chapter 16 Alcohol
16.1 Introduction
16.2 Anxiety and performance
16.3 Metabolism of alcohol
16.4 Action of alcohol on the nervous system
16.5 Alcohol and health
16.6 Alcohol and physiological responses to exercise
16.7 Alcohol in aiming sports
16.8 Alcohol and sports accidents
16.9 Overview
16.10 References
Chapter 17 Beta blockers
17.1 What are beta blockers?
Mode of action of beta blockers
Effects of beta blockers
Side effects of beta blockers
17.2 History of beta blockers in sport
17.3 Beta blockers and the WADA prohibited list
WADA regulations with respect to beta blockers
Prevalence of adverse findings for beta blockers
17.4 The use of beta blockers in sport
Adverse effects of beta blockers in sport
Potential benefit of beta blockers in sport
17.5 References
Section 3 Substances and methods permitted in sport
Chapter 18 Supplements for high intensity exercise
18.1 Introduction
18.2 Energy metabolism and fatigue
18.3 Creatine
Muscle creatine loading
Creatine and performance
Creatine and single bouts of high intensity exercise
Creatine and repeated bouts of high intensity exercise
Creatine and strength
18.4 Sodium bicarbonate
18.5 Beta-alanine
18.6 Conclusion
18.7 References
Chapter 19 Supplement use in sport
19.1 Introduction
19.2 Extent of supplement use
19.3 Why supplements are used
19.4 Types of supplements
Classification
Vitamins
Proteins and amino acids
Carbohydrates
Ginseng
Creatine
L-Carnitine
Caffeine
Glucosamine
19.5 Availability of supplements
19.6 Problems associated with supplement use
WADA regulations
Misleading advertising, inaccurate labelling and supplement contamination
Accuracy and quality of advice on supplement use
Case studies involving supplements
Professional footballers in 2001
Greg Rusedski, 2003
19.7 Advice for athletes
19.8 References
Chapter 20 Caffeine
20.1 Introduction
20.2 Pharmacology
20.3 Mechanisms of action
20.4 Performance-enhancing properties
Endurance exercise
Anaerobic exercise
Resistance exercise
Intermittent exercise
Cognitive function
20.5 Caffeine combinations
20.6 Therapeutic actions
20.7 Adverse side effects
20.8 Caffeine use and WADA regulations
20.9 Summary
20.10 References
Chapter 21 Over-the-counter stimulants and herbal preparations
21.1 Introduction
21.2 Upper respiratory tract (URT) conditions and exercise
21.3 Treatment of URT conditions
The common cold and influenza
Sinusitis
Allergic rhinitis
21.4 Weight loss
21.5 Relief from fatigue and drowsiness
21.6 Sympathomimetic amines
Potential side effects of sympathomimetic amines
Reputed ergogenic effects
Sympathomimetic amine use and WADA regulations
21.7 Methylxanthines
21.8 OTC herbal stimulants
Guarana
Ephedra sinica/Ma Huang
Citrus aurantium
21.9 Summary
21.10 References
Chapter 22 Non-steroidal anti-inflammatory drugs
22.1 Introduction
22.2 The inflammatory response
Changes in microcirculation during the inflammatory response
Leucocytes in inflammation
Acute and chronic inflammation
22.3 The treatment of sporting injuries
The use of non-steroidal anti-inflammatory drugs to treat inflammatory conditions
Aspirin
Naproxen
Ibuprofen
Indomethacin
Piroxicam
Diclofenac
Phenylbutazone
Equestrian sport
Duration of NSAID treatment
The use of NSAIDs to enhance performance in endurance sports
Topical NSAIDs in sports injury
22.4 References
Chapter 23 Melatonin and related substances
23.1 Background
23.2 Melatonin and biological rhythms
23.3 Other properties of melatonin
23.4 Exercise and the melatonin rhythm
23.5 Melatonin and thermoregulation
23.6 Melatonin and jet-lag
23.7 Alternatives to melatonin: the benzodiazepines
23.8 Overview
23.9 References
Chapter 24 Hypoxic chambers and other artificial environments
24.1 Introduction
24.2 Exercise at altitude
24.3 Adaptations to altitude
Physiological adaptations
Altitude simulation
Does it work?
How does it work?
24.4 WADA attitude to artificially induced hypoxic conditions
24.5 Conclusion
24.6 References
Section 4 The extent of doping in sport
Chapter 25 Prevalence of drug misuse in sport
25.1 Introduction
25.2 Statistics on doping control in sport
Statistics from WADA-accredited laboratories
Statistics derived from national surveys
25.3 Surveys into drug misuse in sport
25.4 A perspective on the prevalence of drug misuse in sport through medical practitioners
25.5 General discussion
25.6 References
Appendix Synopsis of drugs used in sport
Section 1. WADA-prohibited drugs and methods
Anabolic androgenic steroids
WADA category
Use in sport
Pharmacological action
Adverse effects
Erythropoietin
WADA category
Use in sport
Pharmacological action
Adverse effects
Human growth hormone and insulin-like growth factor
WADA category
Use in sport
Pharmacological action
Adverse effects
β2-agonists
WADA category
Use in sport
Pharmacological action
Adverse effects
Diuretics
WADA category
Use in sport
Pharmacological action
Adverse effects
Blood doping
WADA category
Use in sport
Adverse effects
Amphetamines
WADA category
Use in sport
Pharmacological action
Adverse effects
Cocaine
WADA category
Use in sport
Pharmacological action
Adverse effects
Ephedrine and other sympathomimetics available in over-the-counter (OTC) medicines
WADA category
Use in sport
Pharmacological action
Adverse effects
Narcotics
WADA category
Use in sport
Pharmacological action
Adverse effects
Cannabinoids
WADA category
Use in sport
Pharmacological action
Adverse effects
Glucocorticosteroids
WADA category
Use in sport
Pharmacological action
Adverse effects
Alcohol
WADA category
Use in sport
Pharmacological action
Adverse effects
Beta blockers
WADA category
Use in sport
Pharmacological action
Adverse effects
Section 2. Drugs used in sport that are not on the WADA prohibited list
Non-steroidal anti-inflammatory drugs (NSAIDs)
Use in sport
Pharmacological action
Adverse effects
Benzodiazepines and other anxiolytics
Use in sport
Pharmacological action
Adverse effects
Caffeine
Use in sport
Pharmacological action
Adverse effects
Cough and cold preparations
Use in sport
Pharmacological action
Adverse effects
Antidiarrhoeals
Use in sport
Pharmacological action
Adverse effects
Nutritional supplements
Use in sport
Pharmacological action
Adverse effects
Index
← Prev
Back
Next →
← Prev
Back
Next →